Lepu Biopharma Co., Ltd. (HKG:2157)

Lepu Biopharma Statistics

Total Valuation

Lepu Biopharma has a market cap or net worth of HKD 11.75 billion. The enterprise value is 11.83 billion.

Market Cap	11.75B
Enterprise Value	11.83B

Important Dates

The last earnings date was Wednesday, March 25, 2026.

Earnings Date	Mar 25, 2026
Ex-Dividend Date	n/a

Share Statistics

Lepu Biopharma has 1.80 billion shares outstanding. The number of shares has increased by 3.82% in one year.

Current Share Class	1.80B
Shares Outstanding	1.80B
Shares Change (YoY)	+3.82%
Shares Change (QoQ)	+5.20%
Owned by Insiders (%)	29.00%
Owned by Institutions (%)	9.83%
Float	934.67M

Valuation Ratios

The trailing PE ratio is 39.28.

PE Ratio	39.28
Forward PE	n/a
PS Ratio	11.29
PB Ratio	7.75
P/TBV Ratio	11.92
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	40.68
EV / Sales	11.37
EV / EBITDA	105.61
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.98, with a Debt / Equity ratio of 0.78.

Current Ratio	0.98
Quick Ratio	0.94
Debt / Equity	0.78
Debt / EBITDA	9.78
Debt / FCF	n/a
Interest Coverage	0.89

Financial Efficiency

Return on equity (ROE) is 25.32% and return on invested capital (ROIC) is 1.77%.

Return on Equity (ROE)	25.32%
Return on Assets (ROA)	0.60%
Return on Invested Capital (ROIC)	1.77%
Return on Capital Employed (ROCE)	1.34%
Weighted Average Cost of Capital (WACC)	2.13%
Revenue Per Employee	1.91M
Profits Per Employee	532,690
Employee Count	546
Asset Turnover	0.35
Inventory Turnover	2.40

Taxes

In the past 12 months, Lepu Biopharma has paid 1.95 million in taxes.

Income Tax	1.95M
Effective Tax Rate	0.67%

Stock Price Statistics

The stock price has increased by +58.01% in the last 52 weeks. The beta is -0.40, so Lepu Biopharma's price volatility has been lower than the market average.

Beta (5Y)	-0.40
52-Week Price Change	+58.01%
50-Day Moving Average	4.97
200-Day Moving Average	6.29
Relative Strength Index (RSI)	71.43
Average Volume (20 Days)	18,569,829

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Lepu Biopharma had revenue of HKD 1.04 billion and earned 290.85 million in profits. Earnings per share was 0.17.

Revenue	1.04B
Gross Profit	940.63M
Operating Income	28.96M
Pretax Income	290.04M
Net Income	290.85M
EBITDA	120.39M
EBIT	28.96M
Earnings Per Share (EPS)	0.17

Balance Sheet

The company has 1.07 billion in cash and 1.18 billion in debt, with a net cash position of -110.53 million or -0.06 per share.

Cash & Cash Equivalents	1.07B
Total Debt	1.18B
Net Cash	-110.53M
Net Cash Per Share	-0.06
Equity (Book Value)	1.52B
Book Value Per Share	0.85
Working Capital	-22.00M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	94.22M
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 90.42%, with operating and profit margins of 2.78% and 27.96%.

Gross Margin	90.42%
Operating Margin	2.78%
Pretax Margin	27.88%
Profit Margin	27.96%
EBITDA Margin	11.57%
EBIT Margin	2.78%
FCF Margin	n/a

Dividends & Yields

Lepu Biopharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.82%
Shareholder Yield	-3.82%
Earnings Yield	2.48%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Lepu Biopharma has an Altman Z-Score of 2.26 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.26
Piotroski F-Score	5